Bayer CropScience Ltd

Q2 FY26Fertilizers & Agrochemicals

Bayer CropScience Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹4,072

Market cap₹19.3K Cr

P/E26.4

Updated23 Aug 2026

Read4 min read

What the Q2 FY26 call signalled

2 of 3 strong

RevenueRank 4

MarginRank 2

CapexYes

Not discussed on this call: fundraise, order book.

The short version

Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years. Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.

From Bayer CropScience Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Rank 4

Aspirational revenue growth target is high single-digit to low double-digit over the next 3-5 years.
Growth driven by a strong, strategic focus on Crop Protection (CP) portfolio backed by innovations and doubling of corn seeds portfolio.
Expect steady improvement in profitability alongside revenue growth, aiming for around 100 basis points margin improvement over 2-3 years starting from FY 2024-25.
Volume growth is important, but margins have limitations, especially in corn due to higher incremental production costs influenced by weather.
Pricing power and competitive positioning through new product launches (e.g., BICOTA, Camalus, Xivana Smart) will support growth.
Sustainable growth requires balancing cost efficiencies, top-line growth, and operational expense control.
Overall guidance assumes normalized operating conditions without major one-time items.

Profitability & Margins

Revenue growth guidance is high single-digit to low double-digit for the next 3-5 years, driven by strategic portfolio focus and doubling corn seeds portfolio.
Profitability expected to improve steadily alongside revenue growth, targeting a 100 basis points (bps) improvement in margin starting from the base year FY24-25 over the next 2-3 years.
Margin improvement depends on multiple factors including supply chain changes and pricing; margins are not expected to reach very high levels (e.g., 50% EBIT margin is unrealistic).
EPS had declined due to high input costs and supply chain challenges but is expected to stabilize as these issues ease.
Growth in revenue and margin improvement are aspirational and assume normal business conditions without one-time costs.
Sustained profitability improvement from FY24-25 is the company's aspiration amidst uncertain market conditions.

See what Bayer CropScience Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.
Significant new product launches are planned, including major proprietary launch "Plenexos" (insecticide) and other compounds like Xivana Smart targeting fruit and vegetable segments.
The company is enhancing backward integration for larger compound manufacturing within India to reduce reliance on imports from high currency countries and improve supply chain resilience.
Go-to-market transformation includes shifting focus toward partnerships and digital channels in less profitable areas to improve operational efficiency and margin per head.
Investment emphasis is on innovation-driven product supply, increased local sourcing in India and Asia, and supporting sustainability and quality standards.
Overall, the strategy involves high single-digit to low double-digit revenue growth supported by capex targeted at innovation, production capacity, and go-to-market recalibration.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The provided transcript from Bayer CropScience Limited's session does not mention any current or planned fundraising through debt or equity. Key points: - Discussions primarily focus on operational costs, supply chain restructuring, product pipeline, margin guidance, and market strategy. - No reference found regarding raising capital via debt or equity instruments. - Focus is on improving margins, managing supply chains, and launching new products. - Emphasis on sustaining profitability, optimizing portfolio, and growth in core business areas. - No indication of external financing plans disclosed in the excerpts provided. Hence, based on the information given on these pages, there is no stated plan for any new fundraising through debt or equity.

See what Bayer CropScience Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided pages from the PDF do not contain any information regarding current, expected order book, or pending orders for Bayer CropScience Limited. The discussions largely revolve around: - Supply chain structure and sourcing strategies. - Margin guidance and cost rationalization. - Growth outlook and product pipeline. - Pricing, operating expenses, and market challenges. No specific data or commentary on order book status or pending orders is mentioned in these pages. If you need, I can assist with other topics or check other parts of the document for order book information.

Bayer CropScience Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Bayer CropScience Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Sumitomo Chemical India Ltd (Q2 FY26)
Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…
Chambal Fertilisers & Chemicals Ltd (Q2 FY26)
Crop Protection and Speciality Nutrients show strong traction with a 28-29% year-on-year revenue growth and 37% growth in contribution margins; 22 new products…
Anya Polytech & Fertilizers Ltd (Q2 FY26)
Packaging segment EBITDA margin is around 10%-12%, while fertilizer segment EBITDA margin is about 20%. Key concall takeaways from Anya Polytech &'s Q2 FY26…
Madhya Bharat Agro Products Ltd (Q2 FY26)
H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability. Key concall takeaways from M B Agro Prod.'s Q2 FY26…

Compare:vs Coromandel International Ltd vs F A C T vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bayer CropScience Ltd Q2 FY26 results?

What is Bayer CropScience Ltd share price analysis?

Bayer CropScience Ltd currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹19,338 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bayer CropScience Ltd planning capital expenditure?

Bayer CropScience is focusing on expanding its corn seeds portfolio, aiming for a continued doubling as part of its 3-5 year strategic framework.

Keep Bayer CropScience Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.